Engineering the delivery system for CRISPR-based genome editing

Glass, Zachary, Lee, Matthew, Li, Yamin, Xu, Qiaobing·2018·Trends in biotechnology
DOI 10.1016/j.tibtech.2017.11.006

Cited by (347)

Items 201–300 of 347

  1. Applications of Functional Genomics for Drug Discovery
    Ami M. Kabadi, Eoin McDonnell, Christopher L. Frank, Lauren Drowley · 2020 · SLAS DISCOVERY
  2. Current Advances Toward the Encapsulation of Cas9
    Vaishnavi Kanduri, Danielle LaVigne, Jessica Larsen · 2021 · ACS Macro Letters
  3. Monitoring and abatement of synthetic pollutants using engineered microbial systems
    Quratulain Maqsood, Nazim Hussain, Aleena Sumrin, Shinawar Waseem Ali, Muhammad Rizwan Tariq, Muhammada Mahnoor · 2024 · Discover Life
  4. Gene editing in the context of an increasingly complex genome
    Kevin Blighe, Larry DeDionisio, Kathleen A. Christie, Bo Chawes, Salar Shareef, Thomais Kakouli‐Duarte, Connie Chao-Shern, Vincent Harding, Rachel S. Kelly, Leandro Castellano et al. · 2018 · BMC Genomics
  5. Genetic Engineering of Carrot
    Rafał Barański, Aneta Łukasiewicz · 2019 · Compendium of plant genomes
  6. Recent advances in the application of polymeric nanoparticles to the pulmonary delivery of mRNA
    Peyton M. Panovich, Aditi Ganesan, Amogh R. Angadi, Alexandra S. Piotrowski-Daspit · 2025 · Nanomedicine
  7. Snail microbiota and snail–schistosome interactions: axenic and gnotobiotic technologies
    Xi Sun, Jinni Hong, Tao Ding, Zhongdao Wu, Datao Lin · 2024 · Trends in Parasitology
  8. Cas9-mediated gene-editing frequency in microalgae is doubled by harnessing the interaction between importin α and phytopathogenic NLSs
    Trang Thi Le, Hong Il Choi, Ji Won Kim, Jin‐Ho Yun, Yoon Hyeok Lee, Eun Jung Jeon, Kil Koang Kwon, Dae‐Hyun Cho, Dong‐Yun Choi, Su‐Bin Park et al. · 2025 · Proceedings of the National Academy of Sciences
  9. CRISPR/Cas9-based knockout pipeline for reverse genetics in mammalian cell culture
    Aleksandra Spiegel, Mandy Bachmann, Gabriel Jurado Jiménez, Mihail Sarov · 2019 · Methods
  10. Genome Editing in Medicine: Tools and Challenges
    Gunda Petraitytė, Eglė Preikšaitienė, Violeta Mikštienė · 2021 · Acta medica Lituanica
  11. An assessment on CRISPR Cas as a novel asset in mitigating drought stress
    Zafar Ali, S. K. Rai, Sami Jan, Kavita Raina · 2022 · Genetic Resources and Crop Evolution
  12. Characterizing genes associated with cancer using the CRISPR/Cas9 system: A systematic review of genes and methodological approaches
    Fernando Gonzalez-Salinas, Claudia Martínez-Amador, Víctor Treviño · 2022 · Gene
  13. RETRACTED ARTICLE: Revolutionizing Lung Cancer Treatment: Innovative CRISPR-Cas9 Delivery Strategies
    Dilpreet Singh · 2024 · AAPS PharmSciTech · Retracted
  14. Translating genomic insights into cardiovascular medicine: Opportunities and challenges of CRISPR-Cas9
    Yuan Zhang, Ioannis Karakikes · 2020 · Trends in Cardiovascular Medicine
  15. Nanoelectrochemical Study of Molecular Transport through the Nuclear Pore Complex
    Shigeru Amemiya · 2021 · The Chemical Record
  16. Insights of CRISPR-Cas systems in stem cells: progress in regenerative medicine
    Dilip Kumar Shanmugam, Manimaran Aashabharathi, Guruviah Karthiga Devi, Ramasamy Subbaiya, Muthupandian Saravanan · 2021 · Molecular Biology Reports
  17. Automated Good Manufacturing Practice-Compatible CRISPR-Cas9 Editing of Hematopoietic Stem and Progenitor Cells for Clinical Treatment of β-Hemoglobinopathies
    Guillermo Ureña-Bailén, Milena Block, Tommaso Grandi, Faidra Aivazidou, Jona Quednau, Dariusz Krenz, Alberto Daniel-Moreno, Andrés Lamsfus‐Calle, Thomas Epting, Rupert Handgretinger et al. · 2023 · The CRISPR Journal
  18. Increasing the precision of gene editing in vitro, ex vivo, and in vivo
    Katherine P. Mueller, Jared Carlson-Stevermer, Krishanu Saha · 2018 · Current Opinion in Biomedical Engineering
  19. Enzymatic noncovalent synthesis of peptide assemblies generates multimolecular crowding in cells for biomedical applications
    Meihui Yi, Weiyi Tan, Jiaqi Guo, Bing Xu · 2021 · Chemical Communications
  20. The use of CRISPR-Cas-based systems in bacterial cell factories
    Gulsen Kolasinliler, Mehdi Movahed Aagre, Cengiz Akkale, Hilal Betül Kaya · 2023 · Biochemical Engineering Journal
  21. Delivery of functional Cas:DNA nucleoprotein complexes into recipient bacteria through a type IV secretion system
    Dolores L. Guzmán-Herrador, Andrea Fernández-Gómez, Florence Depardieu, David Bikard, Matxalen Llosa · 2024 · Proceedings of the National Academy of Sciences
  22. Improving the use of CRISPR/Cas9 gene editing machinery as a cancer therapeutic tool with the help of nanomedicine
    Hina Fatima, Dimple Singh, Huzaifa Muhammad, Swati Acharya, Mohammad Azhar Aziz · 2024 · 3 Biotech
  23. The Application of the CRISPR/Cas9 System in the Treatment of Hepatitis B Liver Cancer
    Wei Lv, Tao Li, Shanshan Wang, Huihui Wang, Xuemei Li, Shubing Zhang, Lianzi Wang, Yuanhong Xu, Wei Wei · 2021 · Technology in Cancer Research & Treatment
  24. Genome Editing in Translational Medicine: An Inventory
    Jochen Dobner, Haribaskar Ramachandran, Andrea Rossi · 2022 · Frontiers in Bioscience-Landmark
  25. Making gene editing accessible in resource limited environments: recommendations to guide a first-time user
    Shivani Goolab, Janine Scholefield · 2024 · Frontiers in Genome Editing
  26. CRISPR-Cas9 based genome editing for defective gene correction in humans and other mammals
    Janardhan Keshav Karapurkar, Ainsley Mike Antao, Kye-Seong Kim, Suresh Ramakrishna · 2021 · Progress in molecular biology and translational science
  27. Delivery of dCas9 Activator System Using Magnetic Nanoparticles Technology as a Vector Delivery Method for Human Skin Fibroblast
    Mahdi Mohammadi Ghanbarlou, Shahriyar Abdoli, Hamed Omid, Leila Qazizadeh, Hadi Bamehr, Mozhgan Raigani, Hosein Shahsavarani, Morteza Karimipour, Mohammad Ali Shokrgozar · 2023 · Magnetochemistry
  28. CRISPR/Cas9-based editing of a sensitive transcriptional regulatory element to achieve cell type-specific knockdown of the NEMO scaffold protein
    Milad Babaei, Yuekun Liu, Shelly M. Wuerzberger‐Davis, Ethan Z. McCaslin, Christopher J. DiRusso, Alan T. Yeo, Larisa Kagermazova, Shigeki Miyamoto, Thomas D. Gilmore · 2019 · PLoS ONE
  29. Attempts to understand the mechanisms of mitochondrial diseases: the reverse genetics of mouse models for mitochondrial disease
    Ishikawa, Kaori, Nakada, Kazuto · 2021 · Biochimica et Biophysica Acta (BBA) - General Subjects
  30. Therapeutic Application of mRNA for Genetic Diseases
    Paul J. L. Schürmann, Stijn v. Breda Vriesman, Jose Castro-Alpízar, Sander A. A. Kooijmans, Edward E. S. Nieuwenhuis, Raymond Michel Schiffelers, Sabine A. Fuchs · 2025 · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology
  31. Room for improvement in the treatment of pancreatic cancer: Novel opportunities from gene targeted therapy
    Michail Galanopoulos, Aris Doukatas, Filippos Gkeros, Nikos Viazis, Christos N. Liatsos · 2021 · World Journal of Gastroenterology
  32. Enzymatic Noncovalent Synthesis for Targeting Subcellular Organelles
    Qiuxin Zhang, Weiyi Tan, Bing Xu · 2022 · ChemPlusChem
  33. CRISPR/dCas9 for hepatic fibrosis therapy: implications and challenges
    Nianan Luo, Wenjun Zhong, Jiangbin Li, Jianguo Lu, Rui Dong · 2022 · Molecular Biology Reports
  34. Modification of the Tumor Microenvironment Enhances Anti-PD-1 Immunotherapy in Metastatic Melanoma
    Guilan Shi, Megan Scott, Cathryn Mangiamele, Richard F. Heller · 2022 · Pharmaceutics
  35. Genome editing by introduction of Cas9/sgRNA into plant cells using temperature-controlled atmospheric pressure plasma
    Yuki Yanagawa, Yuma Suenaga, Yusuke Iijima, M. Endo, Naoko Sanada, Etsuko Katoh, Seiichi Toki, Akitoshi Okino, Ichiro Mitsuhara · 2023 · PLoS ONE
  36. Biogenic materials for CRISPR delivery and therapeutics
    Kaiyong Yang, Jing Qian, Chunli Zhang, Zeyu Wang, Qiqing Huang, Gaoyu Shi, Zhenyu Zhang, Yanru Yang, Xin Han · 2023 · Biomaterials Science
  37. Prospects and challenges of CRISPR /Cas9 gene‐editing technology in cancer research
    Ning Li, Jiahui Xi, Zi Yin, Min Chen, Qingjian Zou, Xiaoqing Zhou, Chengcheng Tang · 2023 · Clinical Genetics
  38. Gene editing in small and large animals for translational medicine: a review
    Clésio Gomes Mariano, Vanessa Cristina de Oliveira Souza, Carlos Eduardo Ambrósio · 2024 · Animal Reproduction
  39. Gene editing strategies to treat lysosomal disorders: The example of mucopolysaccharidoses
    Flávia Nathiely Silveira Fachel, Lariane Frâncio, Édina Poletto, Roselena Silvestri Schuh, Hélder Ferreira Teixeira, Roberto Giugliani, Guilherme Baldo, Úrsula da Silveira Matte · 2022 · Advanced Drug Delivery Reviews
  40. An oncogenic splice variant of PDGFRα in adult glioblastoma as a therapeutic target for selective CDK4/6 inhibitors
    Taiji Hamada, Toshiaki Akahane, Seiya Yokoyama, Nayuta Higa, Mari Kirishima, Kei Matsuo, Michiko Shimokawa, Koji Yoshimoto, Akihide Tanimoto · 2022 · Scientific Reports
  41. From Origin to the Present: Establishment, Mechanism, Evolutions and Biomedical Applications of the CRISPR/Cas-Based Macromolecular System in Brief
    Zheng Yuan · 2025 · Molecules
  42. Strategies and mechanisms of precision genome engineering: From gene editing to genome writing
    Kerui Huang, Jianhong Tian, Wenyan Zhao, Siqin Zhang, Lixuan Xiang, Meiqing Yang, Liu Ls, Y Huang, Ningyun Zhang, Lei Sun et al. · 2026 · iMetaOmics.
  43. Tetrazine-Ligated CRISPR sgRNAs for Efficient Genome Editing
    Zexiang Chen, Gitali Devi, Amena Arif, Phillip D. Zamore, Erik J. Sontheimer, Jonathan K. Watts · 2022 · ACS Chemical Biology
  44. Bacterial enzymes: powerful tools for protein labeling, cell signaling, and therapeutic discovery
    Lu Liu, Janine L. Gray, Edward W. Tate, Aimin Yang · 2023 · Trends in biotechnology
  45. CRISPR/Cas9-mediated silencing of CD44: unveiling the role of hyaluronic acid-mediated interactions in cancer drug resistance
    Zhujun Xu · 2023 · Naunyn-Schmiedeberg s Archives of Pharmacology
  46. Lipids and lipid derivatives for delivery of the CRISPR/Cas9 system
    Zaid Saad Madhi, Mohammed Ali Shallan, Abdulhusein Mizhir Almaamuri, Ammar Abbas Alhussainy, Sadiq Salam H. AL-Salih, Abdulla K. Raheem, Hameed Jassem Alwan, Abduladheem Turki Jalil · 2022 · Journal of Drug Delivery Science and Technology
  47. Wheat pollen uptake of CRISPR/Cas9 RNP-PDMAEMA nanoassemblies results in targeted loss of gene function in progeny
    Neelam Gogoi, Mehwish Kanwal, Michael Norman, Jacob Downs, Nabil Ahmad, Rohit Mago, Harbans S. Bariana, Markus Müllner, Urmil K. Bansal, Brian Joseph Jones · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  48. CRISPR-Cas technologies: Emerging tools from research to clinical application
    Hana Hyeon, Soonhye Hwang, Yongyang Luo, Eunkyoung Shin, Ji‐Hyun Yeom, Hong‐Man Kim, Minkyung Ryu, Kangseok Lee · 2025 · The Journal of Microbiology
  49. CRISPR-Cas9/Cas12a-based genome editing in Atlantic cod (Gadus morhua)
    Adrián López‐Porras, Ragnhild Stenberg Berg, Erik Burgerhout, Øyvind J. Hansen, Ádám Györkei, Shuo‐Wang Qiao, Finn–Eirik Johansen · 2023 · Aquaculture
  50. Design and Assembly of CRISPR/Cas9 Lentiviral and rAAV Vectors for Targeted Genome Editing
    Ivette M. Sandoval, Timothy J. Collier, Fredric P. Manfredsson · 2019 · Methods in molecular biology
  51. Memoria inmunológica innata, la pieza faltante de la respuesta inmunológica
    Diego Pérez-Vázquez, Eugenio Contreras-Castillo, Paula Licona-Limón · 2018 · TIP Revista Especializada en Ciencias Químico-Biológicas
  52. CRISPR-Cas9 system for fungi genome engineering toward industrial applications
    Lakkakula Satish, Sasanala Shamili, Balasubramanian Chellammal Muthubharathi, Stanislaus Antony Ceasar, Ariel Kushmaro, Vijai Singh, Yaron Sitrit · 2020 · Elsevier eBooks
  53. CAP-LAMP2b–Modified Stem Cells’ Extracellular Vesicles Hybrid with CRISPR-Cas9 Targeting ADAMTS4 to Reverse IL-1β–Induced Aggrecan Loss in Chondrocytes
    Kun‐Chi Wu, Yu‐Hsun Chang, Raymond Yuh-Shyan Chiang, Dah‐Ching Ding · 2025 · International Journal of Molecular Sciences
  54. Engineering Lipid Nanoparticles for Precision RNA Delivery: Design Principles, Targeting Strategies, and Clinical Prospects
    Yu Han, Ying Wang, Xintao Gao, Yan Lei, Yantao Li, Zhiyong Tang · 2026 · Cancer Nexus
  55. Advances in CRISPR Base Editing: From Molecular Evolution to Therapeutic Applications in Genomic Medicine
    Melike Aliciaslan, Ezgi Erbasan, Fulya Erendor, Salih Şanlıoğlu · 2026 · Journal of Cellular and Molecular Medicine
  56. Current Landscape of Various Techniques and Methods of Gene Therapy through CRISPR Cas9 along with its Pharmacological and Interventional Therapies in the Treatment of Type 2 Diabetes Mellitus
    Pranay Wal, Namra Aziz, Harshit Prajapati, Shashank Soni, Ankita Wal · 2023 · Current Diabetes Reviews
  57. RNA-Based Vaccines and Therapeutics Against Intracellular Pathogens
    Naga Suresh Kola, Dhruv Patel, Aneesh Thakur · 2024 · Methods in molecular biology
  58. Prime Editing in Mammals: The Next Generation of Precision Genome Editing
    Dawei Wang, Xiude Fan, Mengzhu Li, Tianbo Liu, Peng Lü, Guangxin Wang, Yuan Li, Junming Han, Jiajun Zhao · 2022 · The CRISPR Journal
  59. Self-Assembled Plasmid Delivery System for PPM1D Knockout to Reverse Tumor Malignancy
    Xiaohe Ren, Xiaoyan He, Boya Liu, Chang Xu, Si‐Xue Cheng · 2020 · ACS Applied Bio Materials
  60. Nonviral vector system for cancer immunogene therapy
    Wen Nie, Jing Chen, Bilan Wang, Xiang Gao · 2022 · MedComm – Biomaterials and Applications
  61. Viral approaches to study the mammalian brain: Lineage tracing, circuit dissection and therapeutic applications
    Wei Cong, Yun Shi, Yanqing Qi, Jinyun Wu, Ling Gong, Miao He · 2020 · Journal of Neuroscience Methods
  62. Orchestrating inflammation: non-coding RNAs as master regulators of macrophage function in chronic obstructive pulmonary disease-an update
    Xinyu Yong, Xian Luo, Xiaobing Chen, Chengxiu Yu · 2025 · Frontiers in Immunology
  63. Cytoplasmic Injection of Zygotes to Genome Edit Naturally Occurring Sequence Variants Into Bovine Embryos
    Jingwei Wei, Brigid Brophy, Sally Cole, Jannis Moormann, Jens Boch, Götz Laible · 2022 · Frontiers in Genetics
  64. High-efficiency editing in hematopoietic stem cells and the HUDEP-2 cell line based on in vitro mRNA synthesis
    Nikoletta Y. Papaioannou, Petros Patsali, Basma Naiisseh, Panayiota L. Papasavva, Lola Koniali, Ryo Kurita, Yukio Nakamura, Soteroula Christou, Maria Sitarou, Claudio Mussolino et al. · 2023 · Frontiers in Genome Editing
  65. Targeting pediatric solid tumors in the new era of RNA therapeutics
    Parunya Chaiyawat, Surasak Sangkhathat, Wararat Chiangjong, Patompon Wongtrakoongate, Suradej Hongeng, Dumnoensun Pruksakorn, Somchai Chutipongtanate · 2024 · Critical Reviews in Oncology/Hematology
  66. Therapeutic promise of CRISPR-Cas9 gene editing in sickle cell disease and β-thalassemia: A current review
    Hassan Hussain Almasoudi · 2025 · Current Research in Translational Medicine
  67. An overview on in-vivo generation of CAR-T cells using CRISPR-loaded functionalized nanocarriers for treating B-cell lineage acute lymphoblastic leukemia
    Tushara Saha, Rudra P. Saha, Manoj Kumar Singh, Kanu Priya, Shareen Singh, Mithul Rajeev, Debasmita Bhattacharya, Moupriya Nag, Dibyajit Lahiri · 2025 · Molecular Biology Reports
  68. Optimizing the delivery of CRISPR/Cas9 ribonucleoproteins for efficient genome editing in bovine embryos
    Xiaofeng Du, Alexander Quinn, Moira Menzies, Laercio R. Porto Neto · 2025 · Gene
  69. Dynamic Genome Editing Using In Vivo Synthesized Donor ssDNA in Escherichia coli
    Min Hao, Zhaoguan Wang, Hongyan Qiao, Peng Yin, Jianjun Qiao, Hao Qi · 2020 · Cells
  70. The potential of CRISPR-Cas9 prime editing for cardiovascular disease research and therapy
    Nikë Bharucha, Ariel Arias, Ioannis Karakikes · 2022 · Current Opinion in Cardiology
  71. The Search of a Molecular “Swiss Knife” for Chloroplast Genomic Editing
    Natalya V. Dorogova, Yuriy V. Sidorchuk · 2023 · Horticulturae
  72. CRISPR/Cas Technology and Innovation: Mapping Patent Law Issues
    Daria Kim, Reto M. Hilty, Elisabeth Hofmeister, Peter R. Slowinski, Miriam Steinhart · 2022 · SSRN Electronic Journal
  73. Therapeutic precision gene editing of cholesterol pathways as a gene therapy strategy for cardiovascular disease
    Ezgi Erbasan, Melike Aliciaslan, Fulya Erendor, Ahter Dilşad Şanlioğlu, Salih Şanlıoğlu · 2025 · Gene Therapy
  74. CRISPR-driven strategies to disrupt methicillin-resistant Staphylococcus aureus biofilms: a review
    Jose Jurel M. Nuevo, Jamil Allen G. Fortaleza, Kevin Smith P. Cabuhat, Christian Joseph N. Ong, Anna C. Jalova, Ferdinand A Mortel, Grace D. Bacalzo · 2026 · Frontiers in Cellular and Infection Microbiology
  75. Regulatory, ethical, and social aspects of CRISPR crops
    Noor‐ul‐Ain, Aiman Arif, Amer Jamil, Ahmad Munir, Aftab Ahmad, Nayla Munawar · 2024 · Elsevier eBooks
  76. Studies on DNA-related enzymes to elucidate molecular mechanisms underlying genetic information processing and their application in genetic engineering
    Yoshizumi Ishino · 2020 · Bioscience Biotechnology and Biochemistry
  77. Plasmid Delivery and Single-Cell Plasmid Expression Analysis for CRISPR/dCas9-Based Epigenetic Editing
    Anna C. H. van den Berg van Saparoea, Quint C. van Loosen, Federica Sarno, Evgenia Ntini, Marianne G. Rots, Rutger A. F. Gjaltema, Pernette J. Verschure · 2024 · Methods in molecular biology
  78. CRISPR/Cas9-mediated genome editing in Ganoderma lucidum: recent advances and biotechnological opportunities
    Dongmei Lv, Yan Xu, Zi-Xu Wang, Qilin Zhang, Jinping Yan, Jun‐Wei Xu · 2025 · World Journal of Microbiology and Biotechnology
  79. SLC1A5-dependent glutamine uptake in hepatocytes promotes liver regeneration
    Yunhao Duan, Sheng Peng, Jinnan Yue, Fan Ding, Xiaoli Chen, Wenqi Pan, Xiaotong Gao, Peilin Pang, Yuting Zhang, Wenrun Wu et al. · 2025 · Hepatology Communications
  80. Re-balancing immunity with CRISPR-Cas9: Novel strategies for cancer and autoimmune disorders
    Xuanqi Ren, Ziyang Zhou, Lingkai Kong, Yibo Guo, Yan Liu, Jiazhen Li, Xiaosong Gu, Chunping Jiang, Junhua Wu · 2026 · Biotechnology Advances
  81. CRISPR Technology in Antiviral Therapy: Advancements, Applications, and Implications
    Chaitra Raghavendra Kulkarni, A. Prajnashree, Sanatkumar Bharamu Nyamagoud · 2025 · D Y Patil Journal of Health Sciences
  82. Advancements in Gene Therapy for Type 2 Diabetes: Insights from CRISPR Cas9 Mediated Gene Editing and Insulin Production
    Sairam Venkatraman, Srinivasan S. Tharun, Ashok Pavithra, Reddy Amala · 2024 · Pharmaceutical science.
  83. Genetic Engineering and Genome Editing Approaches for Identification and Sustainable Management of Insect Pests Under Forest Dynamics
    Tanmaya Kumar Bhoi, Ipsita Samal, Deepak Kumar Mahanta, J. Komal, Prasanta Kumar Majhi, Shiwani Bhatnagar · 2024 · Springer eBooks
  84. Challenges and Future Perspective of CRISPR/Cas Technology for Crop Improvement
    Zulqurnain Khan, Sultan Habibullah Khan, Aftab Ahmad · 2021 · Springer eBooks
  85. Newborn Intravenous Injection of Liposomal CRISPR/Cas9 Complex Has No Incidence of Off-Targets or Tumors in Mice
    Vinícius Monteagudo de Barros, Larissa Cristina Barbosa Flores, Melaine Lopes, Flávia Nathiely Silveira Fachel, Giselle Renata Martins, Marina Siebert, Willian da Silva Carniel, Tuane Nerissa Alves Garcez, Hélder Ferreira Teixeira, Úrsula da Silveira Matte et al. · 2025 · Pharmaceutics
  86. Light-controlled CRISPR–dCas9 epigenome editing: advanced drug-delivery strategies and oncology applications
    Naiyereh Alipour Eskandani, Danial Mirzaee, Marzieh Ramezani Farani, Afrooz Hatami, Mohsen Hatami, Maryam Ghasemzaei, Seyed Majid Ghoreishian, Seung-Kyu Hwang, Yun Suk Huh · 2026 · Advanced Drug Delivery Reviews
  87. Multicellular systems to translate somatic cell genome editors to human
    Victor Hernandez‐Gordillo, Thomas Caleb Casolaro, Mo R. Ebrahimkhani, Samira Kiani · 2020 · Current Opinion in Biomedical Engineering
  88. Nonviral gene editing in cancer immunotherapy
    Yamin Li, Qiaobing Xu · 2021 · Elsevier eBooks
  89. Crosslinked Protein Delivery Strategy with Precise Activity Regulation Properties for Cancer Therapy and Gene Editing
    Ning Liu, Lianghan Zhu, Honghao Sun, Zhanwei Zhou, Jingwen Dong, Minjie Sun · 2022 · Advanced Healthcare Materials
  90. Chemical Modification of Proteins and Their Intracellular Delivery Using Lipidoid Nanoparticles
    Yamin Li, Zachary Glass, Qiaobing Xu · 2022 · Methods in molecular biology
  91. Targeted Gene Delivery Through Magnetofection: The New Face of Medicine
    Jagmohan Singh, Ipsita Mohanty, R.C. Sobti, Satish C. Rattan · 2022 · Springer eBooks
  92. Single-Cell Synchro-Subtractive–Additive Nanoscale Surgery with Femtosecond Lasers
    Shuyuan Qu, Chenqi Yi, Qin Ping Zhao, Yueqi Ni, Simin Ouyang, Haoning Qi, Gary J. Cheng, Yufeng Zhang · 2024 · Nano Letters
  93. FOSTERING CREATIVITY IN COMPUTER SUPPORTED COLLABORATIVE LEARNING ACTIVITIES
    Dimitrios Lappas, Georgios Fessakis · 2014 · INTED proceedings
  94. Gene Therapy for Duchenne Muscular Dystrophy
    Marisa Wen · 2021
  95. Challenges and Future Outlook in Employing Nanomaterials for Gene Delivery and Editing in Plants
    Mohd Anas, Sana Basri, Bushra Fatima · 2025 · Sustainable development and biodiversity
  96. CRISPR/Cas9-integrated nanocarriers for cancer gene therapy: Mechanistic insights, challenges, and clinical translation
    Abhay Thakur, Rahul Sharma, Rohit Sharma, Kamal Jeet, Amar Deepak · 2025 · Journal of Drug Delivery Science and Technology
  97. Harnessing CRISPR-Cas technology for insect pest control: current advances and future perspectives
    Nareshkumar Arjunan, V. Thiruvengadam · 2026 · Molecular Biology Reports
  98. CRISPR in the Tumor Microenvironment: From Diagnostic Profiling to Precision Therapy
    Lirenhui Zhou, Meiya Mu, Meihua Yang, Xiaojing Liu, Guangrong Zou, Chaoxing Liu · 2026 · Cancer Biome and Targeted Therapy
  99. Advances in improving cancer immunotherapy with nanotechnology: from smart nanoparticles to synergistic combination strategies
    Untack Cho, Jingjing Pu, Amit Sharma, Junhyuk Song, Ji Hyeon You, Yona Kim, Pyung Won Im, Hyun Woo Park, Hyo Eun Moon, Ho Sung Myeong et al. · 2026 · Molecular Cancer
  100. Reagents and their delivery systems in CRISPR/Cas
    Sehrish Khan, Hassan Zafar, Aftab Ahmad · 2024 · Elsevier eBooks